Diabetic Human Mesenchymal Stem Cells Release Extracellular Vesicles with Distinct Size and Zeta Potential Properties

Diabetic Human Mesenchymal Stem Cells Release Extracellular Vesicles with Distinct Size and Zeta Potential Properties


چاپ صفحه
پژوهان
صفحه نخست سامانه
نویسندگان
نویسندگان
اطلاعات تفضیلی
اطلاعات تفضیلی
دانلود مقاله
دانلود مقاله
دانشگاه علوم پزشکی تبریز
دانشگاه علوم پزشکی تبریز

نویسندگان: رضا رهبرقاضی

عنوان کنگره / همایش: سومین جشنواره ملی و کنگره بین المللی علوم و فناوری سلول های بنیادی و پزشکی بازساختی , Iran (Islamic Republic) , Tehran , 2018

اطلاعات کلی مقاله
hide/show

نویسنده ثبت کننده مقاله رضا رهبرقاضی
مرحله جاری مقاله تایید نهایی
دانشکده/مرکز مربوطه مرکز سلولهای بنیادی
کد مقاله 65488
عنوان فارسی مقاله Diabetic Human Mesenchymal Stem Cells Release Extracellular Vesicles with Distinct Size and Zeta Potential Properties
عنوان لاتین مقاله Diabetic Human Mesenchymal Stem Cells Release Extracellular Vesicles with Distinct Size and Zeta Potential Properties
نوع ارائه پوستر
عنوان کنگره / همایش سومین جشنواره ملی و کنگره بین المللی علوم و فناوری سلول های بنیادی و پزشکی بازساختی
نوع کنگره / همایش بین المللی
کشور محل برگزاری کنگره/ همایش Iran (Islamic Republic)
شهر محل برگزاری کنگره/ همایش Tehran
سال انتشار/ ارائه شمسی 1397
سال انتشار/ارائه میلادی 2018
تاریخ شمسی شروع و خاتمه کنگره/همایش 1397/09/07 الی 1397/09/10
آدرس لینک مقاله/ همایش در شبکه اینترنت
آدرس علمی (Affiliation) نویسنده متقاضی Stem Cell Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

نویسندگان
hide/show

نویسنده نفر چندم مقاله
رضا رهبرقاضیپنجم

اطلاعات تفضیلی
hide/show

عنوان متن
خلاصه مقالهBackground and Aim: Extracellular vesicles (EVs) are nano-sized vesicles released by many cells as intercellular communication tools. Recent studies have shown that diabetes mellitus (DM) affects the biology of stem cells especially mesenchymal stem cells (hMSCs) through changes in their secretome. We aimed to study the effect of serum from type 2 diabetic mellitus patients on the size and Zeta potential (ZP) of hMSCsderived EVs in vitro. Methods: hMSCs were allocated into two groups as follows; Control (cells received DMEM/LG and 10% sera from healthy subjects) and Diabetic (cells received DMEM/LG and 10% diabetic sera). Treatment was carried out for a period of 7 days. EVs were then isolated according to the isolation kit (Publication No: MAN0006949, Invitrogen) instructions. Flow cytometry and scanning electron microscopy were used to characterize the EVs. To analyze size distribution and ZP, EVs were subjected to the Zetasizer Nano Z system (Nano ZS ZEN 3600, Malvern). Furthermore, to determine whether the DM sera could affect the dynamic of the fatty acids profile, we used Gas Chromatography (GC). Data are expressed as means ± SD. Student’s t-test was used to calculate the significance of differences between the groups. Values of P<0.05 were considered statistically significant. Results: The size of the EVs derived from the diabetic group significantly increased compared to the control group (p control versus diabetic <0.05). Furthermore, in comparison with the control group, the ZP of diabetic hMSCs-derived EVs significantly decreased (p control versus diabetic <0.05). Data from GC showed that treatment with DM sera resulted in a highly significant increase in the content of Palmitate (16:0) (p control versus diabetic <0.01) and a significant decrease in the content of Myristate (14:0) and Linoleate (18:2) compared to the control group (p control versus diabetic <0.05).No significant differences in the content of other fatty acids between the control and diabetic groups were observed (p control versus diabetic >0.05). Conclusion: We conclude that diabetic mellitus alters the properties of EVs and the fatty acid profile leading to modifications in the cell biology of hMSCs.
کلمات کلیدیExtracellular vesicles; Mesenchymal stem cell; Diabetes mellitus; Zeta potential

لینک دانلود مقاله
hide/show

نام فایل تاریخ درج فایل اندازه فایل دانلود
image.jpg1397/10/09359866دانلود
Diabetic Human.pdf1397/10/09227872دانلود